8 July 2024 July 2024 decisions news release SMC advice on eight new medicines The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has today (Monday, July 8) published advice on eight medicines.
20 June 2024 NICE issues final draft guidance on multiple technology appraisal (MTA), ivacaftor–tezacaftor–elexacaftor, tezacaftor–ivacaftor and lumacaftor– ivacaftor for treating cystic fibrosis. NICE issues final draft guidance on multiple technology appraisal (MTA), ivacaftor–tezacaftor–elexacaftor, tezacaftor–ivacaftor and lumacaftor– ivacaftor for treating cystic fibrosis.
10 June 2024 June 2024 decisions news release SMC advice on six new medicines The Scottish Medicines Consortium (SMC), which advises on newly-licensed medicines for use by NHSScotland, has today (Monday, June 10) published advice on six medicines.
13 May 2024 May 2024 decisions news release SMC advice on two new medicines The Scottish Medicines Consortium (SMC), which advises on newly-licensed medicines for use by NHSScotland, has today (Monday, May 13) published advice on two medicines.
8 May 2024 SMC publishes Collaborative Advice Documents for remdesivir and tixagevimab plus cilgavimab for COVID-19
9 April 2024 NICE issues final draft guidance for use of remdesivir and also for tixagevimab-cilgavimab (Evusheld®) for treatment of COVID-19 Final draft guidance for remdesivir and for tixagevimab-cilgavimab has been published by the National Institute for Health and Care Excellence (NICE).
8 April 2024 April 2024 decisions news release SMC advice on seven new medicines The Scottish Medicines Consortium (SMC), which advises on newly-licensed medicines for use by NHSScotland, has today (Monday, March 11) published advice on seven medicines.
13 March 2024 SMC publishes an updated Collaborative Advice Document for COVID-19 medicines; update for nirmatrelvir plus ritonavir (partial review of TA878) SMC publishes an updated Collaborative Advice Document for COVID-19 medicines; update for nirmatrelvir plus ritonavir (Paxlovid) (partial review of TA878)
11 March 2024 March 2024 decisions news release SMC advice on five new medicines The Scottish Medicines Consortium (SMC), which advises on newly-licensed medicines for use by NHSScotland, has today (Monday, March 11) published advice on five medicines.
1 March 2024 Change to SMC outwith remit criteria SMC has introduced a more streamlined and consistent approach for biosimilar, generic and hybrid medicines.